Clinical Nuclear Medicine

Skip Navigation LinksHome > September 2007 - Volume 32 - Issue 9 > The Effect of High-Dose Radioiodine Treatment on Lacrimal Gl...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e318124fdb6
Interesting Image

The Effect of High-Dose Radioiodine Treatment on Lacrimal Gland Function in Patients With Differentiated Thyroid Carcinoma

Fard-Esfahani, Armaghan MD; Mirshekarpour, Hossein MD; Fallahi, Babak MD; Eftekhari, Mohammad MD; Saghari, Mohsen MD; Beiki, Davood PhD; Ansari-Gilani, Kianoush MD; Takavar, Abbas PhD

Collapse Box

Abstract

Purpose: There are a limited number of case reports confirming the radioiodine (I-131) presence in tears and only a few case reports of lacrimal gland dysfunction after I-131 therapy. This study was designed to clarify whether lacrimal gland function can be affected by I-131 therapy.

Materials and Methods: We studied 100 eyes of 50 patients who had received high doses of I-131 for treatment of differentiated thyroid carcinoma and 100 eyes of 50 age- and sex-matched control individuals without a history of interfering conditions. The exposed group was studied at least 3 months after their last I-131 therapy. Dry eye symptoms and Schirmer test values (wetting level in millimeters per 5 minutes) of an exposed group were compared with those of an unexposed group.

Results: Fifty-one percent of the exposed eyes and 50% of the unexposed ones revealed at least 1 of the dry eye symptoms. There was no significant difference in symptoms between 2 groups, except for burning sensation and eye redness, which were significantly higher in the exposed eyes. A lower Schirmer test value was noted in the exposed group, 14.5 ± 10.8 mm, when compared with that in controls, 18.2 ± 11.0 mm (P = 0.016), and the relative risk of an abnormal Schirmer test in exposed cases to control group was 1.78 ± 0.62. Correlation coefficient analysis showed no significant relationship between Schirmer test values and cumulative doses of administered I-131.

Conclusions: Reduction in the tear secretion from lacrimal glands is seen after high-dose I-131 therapy; however, their symptoms are no greater than an unexposed population.

© 2007 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.